keep away from moisture
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
LCKLSL hydrochloride, an N-terminal hexapeptide and competitive annexin A2 (AnxA2) inhibitor, effectively disrupts the interaction between tissue plasminogen activator (tPA) and AnxA2. It additionally hinders plasmin generation and exhibits anti-angiogenic properties [1].
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
5 mg | Inquiry | Inquiry | |
50 mg | Inquiry | Inquiry |
Description | LCKLSL hydrochloride, an N-terminal hexapeptide and competitive annexin A2 (AnxA2) inhibitor, effectively disrupts the interaction between tissue plasminogen activator (tPA) and AnxA2. It additionally hinders plasmin generation and exhibits anti-angiogenic properties [1]. |
In vitro | In retinal microvascular endothelial cells (RMVEC), treatment with LCKLSL hydrochloride (0-2 mg) inhibits plasminogen activator production and suppresses VEGF-induced tPA activity under hypoxic conditions [1]. |
In vivo | LCKLSL hydrochloride has demonstrated inhibitory effects on angiogenic responses in two in vivo angiogenesis models (chicken chorioallantoic membrane and mouse matrigel plug assay). Treatment with LCKLSL hydrochloride peptides significantly reduced vascular length. At a concentration of 5 μg/mL, the peptide notably decreased the number of vascular branches, junctions, and tips [1]. |
Molecular Weight | 712.34 |
Formula | C30H58ClN7O8S |
keep away from moisture
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
LCKLSL hydrochloride inhibitor inhibit